home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Safety Assessment of Cosmetic Ingredients and Formulations: The Basics

 
  November 07, 2011  
     
 
CfPA - The Center for Professional Advancement, 90 Minute Accredited Online Training
December 15, 2011 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend
This online training is intended for professionals in the cosmetic and personal care or related industries that specialize in the following disciplines, as well as groups and companies who provide services in these areas:

  • Research and development 
  • Safety assessment 
  • Regulatory affairs 
  • Formulations development 
  • Product development

Description
In the current environment of establishing regulations and environmental issues awareness, an effort is put together to offer guidance to professionals in the industry who are concerned with present approaches and future implications.

This training is aimed at providing key reasons, rationale, tools and approaches to test the safety of ingredients and formulations in the cosmetic and personal care industry.

With the unique position of this industry’s ban of testing on animals as well as the emergence of REACH, this training is designed to present key parties involved and sources of information.

The core of this 90-minute accredited online training will focus on currently available methodologies, their scope and limitations. This training will include opportunities for learning assessment.

Review of Learning Objectives
Module 1: The Need for Safety Studies of Cosmetic Ingredients and Products

  • The status of REACH
  • The 7th amendment
  • Organizations involved:
    – Safe Cosmetic Alliance
    – OECD
    – ECVAM
    – CAAT at John Hopkins University
  • The importance of skin cell culture models

Module 2: Toxicological Measures for Consideration   • Site of application
  • Level of exposure
  • Duration of application
  • Skin condition
  • Pregnancy and maternity
  • Population (age, race)

Module 3: Illustration of Key Validated and Partially Validated Methodologies
  • Skin irritation
  • Phototoxicity
  • Eye irritation
Summary

Question and Answer Session

 
 
Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Dr. Nava Dayan, Skin Care Research Expert

Dr. Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University, and the Research and Development and Safety Assessment Director at Lipo Chemicals Inc. During her 24 years of experience she has specialized in a variety of areas related to skin treatment:

  • The research and understanding of the interaction between topically applied 
    compounds and the skin
  • Findings in skin biochemistry and especially the upper layer of the skin–
    the stratum corneum
  • Delivery of active compounds into and through the skin and the development of delivery 
    systems to facilitate transport, improve bio-availability and reduce toxicity
  • Design and development of topically applied formulations
  • Design of clinical studies to substantiate market claims and to assure safety
  • Academic teaching and lecturing
  • Industrial experience in both development of active compounds, delivery systems and 
    finished formulations
  • Skin absorption studies in vivo and in vitro for safety/efficacy assessment
  • In vitro methodologies for safety assessment of topically applied compounds

Dr. Dayan has received numerous awards of excellence for various papers she has authored. She is the author and co-author more than 150 publications including book chapters and was granted 8 patents. She is also the editor of the “Skin Aging Hand Book” published by Elsevier; “Innate Immunity of Skin and Oral Mucosa” Book co-edited with Prof. Philip Wertz, “Formulating Skin Care with Natural Products” Book co-edited with Dr. Lambros Kromidas; both published by Wiley and sons. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS). She is serves as the Educational Chair of the NYSCC Chapter and on the Scientific Advisory Board of Health Beauty America Expo and the Center for Dermal Research at the Center for Biomaterials. Dr. Dayan teaches at Rutgers University and is the Director of a variety of courses at the Center for Professional Advancement.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.